Endologix® Inc. announced that it has received a CE Mark for the ALTO™ Abdominal Stent Graft System (ALTO). ALTO will provide physician partners and patients in the EU with a differentiated low profile endovascular treatment option designed to improve durability over traditional EVAR. In addition, with ALTO, anticipate observing improved short-term outcomes relative to the Ovation iX Abdominal Stent Graft System (Ovation iX) as a result of the design and manufacturing changes incorporated into ALTO. Lastly, CE Mark of the ALTO system is yet another critical milestone for Endologix as seek to introduce a portfolio of devices to address the current unmet needs of endovascular aneurysm repair (EVAR).